FDA Approved: CYCLOSPORINE — Original Application (Devatis Inc.)

View source ↗

Summary

FDA approved Devatis Inc.'s cyclosporine as a generic drug under an original ANDA (ANDA209811).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection
• Psoriasis
• Rheumatoid Arthritis

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

ORIG AP for CYCLOSPORINE (CYCLOSPORINE)